Article
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.
Nature communications - 3 Sept 2015
Krarup Anders, Truan Daphné, Furmanova-Hollenstein Polina, Bogaert Lies, Bouchier Pascale, Bisschop Ilona J M, Widjojoatmodjo Myra N, Zahn Roland, Schuitemaker Hanneke, McLellan Jason S, Langedijk Johannes P M
Abstract excerpt
Respiratory syncytial virus (RSV) causes acute lower respiratory tract infections and is the leading cause of infant hospitalizations. Recently, a promising vaccine antigen based on the RSV fusion protein (RSV F) stabilized in the native prefusion conformation has been described. Here we report a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
